An apparatus and a method for electroporating tissue. At least one micropore is formed to a predetermined depth through a surface of the tissue, and electrical voltage is applied between an electrode electrically coupled to the micropore and another electrode spaced therefrom. By applying electroporation to tissue that has been breached by a micropore, the electroporation effects can be targeted at tissue structures beneath the surface, such as capillaries, to greatly enhance the withdrawal of biological fluid, and the delivery for uptake of compounds into the tissue. In a preferred embodiment, a device is provided having elements that are suitable for microporating the tissue and which serve as the electroporation electrodes.

Patent
   6022316
Priority
Mar 06 1998
Filed
Mar 06 1998
Issued
Feb 08 2000
Expiry
Mar 06 2018
Assg.orig
Entity
Large
186
10
all paid
1. A method for electroporating tissue, comprising the steps of:
forming at least one micropore to a predetermined depth through a surface of the tissue;
positioning at least a first electrode on the surface of the tissue electrically coupled to the at least one micropore and a second electrode on the surface of the tissue spaced apart from the first electrode; and
applying an electrical voltage between the first and second electrodes to produce a desired electroporation in the tissue.
39. A method of collecting biological fluid from tissue, comprising the steps of:
forming at least one micropore to a predetermined depth through a surface of the tissue;
positioning at least a first electrode electrically coupled to the at least one micropore and a second electrode spaced apart from the first electrode;
applying an electrical voltage between the first and second electrodes to produce a desired electroporation in the tissue; and
collecting biological fluid from the tissue through the at least one micropores.
22. An apparatus for microporation and electroporation of tissue, comprising:
(a) a heated probe suitable for conducting heat to a surface of the tissue to form at least one micropore therein;
(b) at least first and second electrodes suitable for being spaced apart from each other on the tissue; and
(c) control means for supplying energy to the heated probe so as to cause formation of the at least one micropore in the tissue, and for applying an electrical voltage between the first and second electrodes suitable for electroporating the tissue.
38. A method for electroporating tissue, comprising the steps of:
forming at least one micropore to a predetermined depth through a surface of the tissue;
positioning at least a first electrode electrically coupled to the at least one micropore and a second electrode spaced apart from the first electrode; and
applying a voltage pulse of a first polarity with respect to the first and second electrodes, followed by a voltage pulse of an opposite polarity with respect to the first and second electrodes to produce a desired electroporation in the tissue.
43. A method for electroporating tissue, comprising the steps of:
forming at least one micropore to a predetermined depth through a surface of the tissue;
positioning at least a first electrode electrically coupled to the at least one micropore and a second electrode spaced apart from the first electrode;
applying suction to the surface of the tissue to deform the surface of the tissue between the first and second electrodes so that the tissue bulges between the first and second electrodes; and
applying an electrical voltage between the first and second electrodes to produce a desired electroporation in the tissue.
18. A method for electroporating tissue, comprising the steps of:
forming at least one micropore to a predetermined depth through a surface of the tissue by placing an electrically heated probe at the surface of the tissue and supplying electrical current to the electrically heated probe so as to ablate the surface of the tissue in order to form the at least one micropore;
positioning at least a first electrode electrically coupled to the at least one micropore and a second electrode spaced apart from the first electrode; and
applying an electrical voltage between the first and second electrodes to produce a desired electroporation in the tissue.
20. A method for electroporating tissue, comprising the steps of:
forming at least one micropore to a predetermined depth through a surface of the tissue by placing first and second electrically heated probes at the surface of the tissue spaced apart from each other and supplying electrical current to each of the first and second electrically heated probes so as to ablate the surface of the tissue in order to form two micropores spaced apart from each other;
positioning at least a first electrode electrically coupled to the at least one micropore and a second electrode spaced apart from the first electrode;
applying an electrical voltage between the first and second electrodes to produce a desired electroporation in the tissue.
42. A method for electroporating tissue, comprising the steps of:
forming at least one micropore to a predetermined depth through a surface of the tissue, wherein the step of forming the at least one micropore comprises applying a photosensitizing material to the surface of the tissue and irradiating the photosensitizing material with optical energy, whereby the photosensitizing material is responsive to the optical energy so as to heat up and conductively transfer heat to the surface of the tissue to form the at least one micropore;
positioning at least a first electrode electrically coupled to the at least one micropore and a second electrode spaced apart from the first electrode; and
applying an electrical voltage between the first and second electrodes to produce a desired electroporation in the tissue.
2. The method of claim 1, wherein the step of applying electrical voltage comprises applying an electrical voltage of a sufficient magnitude between the first and second electrodes suitable to produce a potential drop exceeding a nominal threshold to achieve electroporation across the epithelial cell layer but not sufficient to electroporate membranes present in other tissue structures thereby achieving a selective electroporation of targeted membranes.
3. The method of claim 1, wherein the step of forming comprises forming first and second micropores spaced apart from each other, and wherein the first electrode is positioned to be electrically coupled to the first micropore, and the second electrode is positioned to be electrically coupled to the second micropore.
4. The method of claim 1, wherein the step of applying electrical voltage comprises applying a voltage pulse of a first polarity with respect to the first and second electrodes, followed by a voltage pulse of an opposite polarity with respect to the first and second electrodes.
5. The method of claim 1, wherein the step of forming comprises forming a plurality of micropores spaced apart from each other in the tissue, and the step of positioning comprises placing a plurality of electrodes each being electrically coupled to a different one of the micropores, and wherein the step of applying electrical voltage comprises applying electrical voltage pulses between different sets of the plurality of electrodes so as to electroporate the tissue in multiple directions.
6. The method of claim 5, wherein the step of applying comprises applying a voltage pulse of a first polarity between a first set of electrodes followed by a voltage pulse of an opposite polarity between the first set of electrodes.
7. A method of collecting biological fluid from the tissue comprising the steps of claim 1, and further comprising collecting biological fluid from the tissue through the at least one micropores.
8. The method of claim 7, and further comprising analyzing the biological fluid with a biosensor.
9. The method of claim 8, wherein the step of analyzing comprises determining a concentration of an analyte in the biological fluid.
10. The method of claim 1, wherein the step of forming the at least one micropore comprises applying a photosensitizing material to the surface of the tissue and irradiating the photosensitizing material with optical energy, whereby the photosensitizing material is responsive to the optical energy so as to heat up and conductively transfer heat to the surface of the tissue to form the at least one micropore.
11. The method of claim 1, and further comprising the step of deforming the surface of the tissue between the first and second electrodes so that the surface of the tissue sufficiently bulges between the first and second electrodes to place tissue structures desired to be electroporated in a principal current path between the first and second electrodes.
12. The method of claim 11, wherein the step of deforming comprises mechanically deforming the surface of the tissue.
13. The method of claim 11, wherein the step of deforming comprises applying suction to the surface of the tissue.
14. The method of claim 1, and further comprising the step of delivering a substance to the tissue at the at least two micropores formed therein.
15. The method of claim 1, wherein the step of forming the at least one micropore comprises applying a photosensitizing material to the surface of the tissue and irradiating the photosensitizing material with optical energy, whereby the photosensitizing material is responsive to the optical energy so as to heat up and conductively transfer heat to the surface of the tissue to form the at least one micropore, whereby the step of positioning the first and second electrodes comprises positioning conductive traces on a tissue-contacting side of the photosensitizing material registered with the micropores.
16. The method of claim 1, and further comprising the step of delivering a permeant into the tissue through the at least one micropore.
17. The method of claim 16, and further comprising the step of delivering a permeant into the tissue so as to cause the permeant to pass through the tissue structures that are electroporated.
19. The method of claim 18, wherein the electrically heated probe also serves as the first electrode such that the electrical voltage is applied between the electrically heated probe and the second electrode.
21. The method of claim 20, wherein the first and second electrically heated probes further serve as the first and second electrodes such that the electrical voltage is applied between the first and second electrically heated probes.
23. The apparatus of claim 22, wherein the control means supplies a magnitude of electrical voltage applied between the first and second electrodes suitable to produce a potential drop exceeding a nominal threshold to achieve electroporation across the epithelial cell layer but not sufficient to electroporate membranes present in other tissue structures thereby achieving a selective electroporation of targeted membranes.
24. The apparatus of claim 22, wherein the heated probe forms first and second micropores spaced apart from each other in the tissue, and wherein the first electrode is suitable for being electrically coupled to the first micropore and the second electrode is suitable for being electrically coupled to the second micropore.
25. The apparatus of claim 22, wherein the heated probe is an electrically heated probe, and wherein the control means supplies electrical current to the electrically heated probe to form the at least one micropore.
26. The apparatus of claim 25, wherein the electrically heated probe also serves as the first electrode such that the electrical voltage is applied between the electrically heated probe and the second electrode.
27. The apparatus of claim 22, wherein the heated probe comprises first and second electrically heated probes spaced apart from each other each responsive to electrical current supplied by the control means to form two micropores in the tissue spaced apart from each other.
28. The apparatus of claim 27, wherein the first and second electrically heated probes further serve as the first and second electrodes, the control means being coupled to the first and second electrically heated probes so as to apply the electrical voltage therebetween.
29. The apparatus of claim 28, and further comprising a tissue-contacting layer supporting the first and second electrically heated probes, and further comprising conductor means for coupling electrical current from the control means to the first and second electrically heated probes, and for applying the electrical voltage between the first and second electrically heated probes.
30. The apparatus of claim 22, wherein the control means applies a first voltage pulse of a first polarity with respect to the first and second electrodes, followed by a voltage pulse of an opposite polarity with respect to the first and second electrodes.
31. The apparatus of claim 22, and comprising a plurality of electrically heated probes each responsive to electrical current and suitable for forming a plurality of micropores spaced apart from each other in the tissue, and wherein the control means applies electrical voltage pulses between different sets of the plurality of electrically heated probes so as to electroporate the tissue in multiple directions.
32. The apparatus of claim 31, wherein the control means applies a voltage pulse of a first polarity between a first set of electrodes followed by a voltage pulse of an opposite polarity between the first set of electrodes.
33. The apparatus of claim 22, and comprising an integrated device for harvesting and analyzing biological fluid, the integrated device comprising a tissue-contact layer and a detecting layer, wherein the heated probe and the first and second electrodes are supported by the tissue-contacting layer, the detecting layer being positioned adjacent the tissue-contacting layer for detecting a characteristic of a biological fluid collected from the tissue through the at least one micropore.
34. The apparatus of claim 33, wherein the detecting layer comprises an electrochemical biosensor.
35. The apparatus of claim 33, wherein the detecting layer comprises a photometric sensor.
36. The apparatus of claim 22, and further comprising a mechanical element suitable for causing the surface of the tissue to sufficiently bulge between the first and second electrodes to place tissue structures desired to be electroporated in a principal current path between the first and second electrodes.
37. The apparatus of claim 22, and further comprising means for applying suction to the tissue so as to suck the surface of the tissue between the first and second electrodes.
40. The method of claim 39, and further comprising the step of analyzing the biological fluid.
41. The method of claim 40, wherein the step of analyzing comprises determining a concentration of an analyte in the biological fluid.

1. Field of the Invention

This invention relates to an apparatus and method for electroporating tissue in which micropores have been formed, for collecting and monitoring biological fluid from the tissue, or for delivery of substances into the tissue.

2. Discussion of the Art

Electroporation of tissue, such as skin, is used to enhance the permeability of the tissue, to facilitate the collection from, or delivery of substances to, the tissue. Electroporation used alone for enhancing the permeability of tissue, such as skin, has limited applications and utility.

Other techniques for enhancing the permeability of tissue surfaces have been developed. One such technology is the microporation of tissue, wherein the tissue surface, such as the skin or mucosal layer, is physically breached by the formation of micropores, approximately 1-1000 μm in diameter. This technology is disclosed in co-pending U.S. patent application Ser. No. 08/776,863, filed Feb. 7, 1997, and entitled "Microporation Of Human Skin For Drug Delivery and Monitoring Applications," the entirety of which is incorporated herein by reference.

Microporation of tissue, such as skin, has been proven significantly effective in the collection of fluids, such as interstitial fluid, for the purposes of quantitating an analyte in the interstitial fluid.

There is, however, room for improving and enhancing the capabilities of microporation and electroporation. In particular, it is desirable to combine the benefits of electroporation and microporation.

Briefly, the present invention is directed to an apparatus and method for electroporating tissue. At least one micropore is formed to a predetermined depth through a surface of the tissue; first and second electrodes are positioned spaced apart on the tissue and one of the electrodes is electrically coupled to the at least one micropore; and an electrical voltage is applied between the electrodes to produce a desired electroporation in the tissue between the electrodes. The electroporation electrodes may also serve the function of participating in the microporation of the tissue. In accordance with a preferred embodiment, a device having elements that are suitable for microporating the tissue and electroporating the tissue is provided.

By microporating the tissue prior to the application of electroporation, the parameters for electroporation can be significantly adjusted and the sensation to the patient can also be reduced. Furthermore, by first breaching the surface of the tissue with micropores, the electroporation can be directed at selected structures in the skin tissue matrix, such as capillaries, vessels, lymphatic paths and the like, so as to enhance the forcing function of interstitial fluid from the microporated tissue, thereby facilitating the collection and analysis of the fluid. In addition, electroporation applied to the capillaries also increases the capillary permeability to substances which are to be delivered into the tissue.

The above and other objects and advantages of the present invention will become more readily apparent when reference is to made to the following description, taken in conjunction with the accompanying drawings.

FIG. 1 is a flow chart generally depicting the overall process employing microporation and electroporation of tissue in accordance with the present invention.

FIG. 2A is a schematic diagram of an apparatus for electroporating tissue according to the present invention.

FIG. 2B is a schematic diagram showing the coupling of electrical current for microporation and electrical voltage for electroporation are supplied to combination electrical heated probes/electroporation electrodes.

FIG. 3 is an enlarged longitudinal cross-sectional view of a device suitable for use in microporating and electroporating tissue.

FIG. 4 is a bottom view of the device of FIG. 3, showing the electrically heated probes used for microporating and electroporating tissue.

FIG. 5 is a graph showing the electrical impedance between an electrically heated probes after micropores are formed in the skin.

FIG. 6 is a side view of a mechanical device suitable for deforming the surface of tissue to enhance the effects of electroporation.

FIG. 7 is a schematic diagram showing the use of a suction device to enhance the effects of electroporation.

FIG. 8 is a schematic diagram of a multiple electrically heated probe array suitable for microporating tissue and electroporating the tissue in multiple directions.

Definitions

As used herein, the expression "biological fluid" is intended to include "interstitial fluid" (ISF), which is the clear fluid that occupies the space between the cells in the body. The term "stratum corneum" means the outermost layer of the skin, consisting of from about 15 to about 20 layers of cells in various stages of drying out. The stratum corneum provides a barrier to the loss of water from inside the body to the external environment and from attack from the external environment to the interior of the body. The term "epidermis" means the region of the skin including the stratum corneum and extending approximately 10 times as thick as the stratum corneum into the body, wherein the portions of the epidermis beneath the stratum corneum is comprised of living, metabolically active cells. The epidermis does not contain capillaries or blood vessels. The term "dermis" means the region of skin approximately 10 times as thick as the epidermis and found just below the epidermis. The dermis contains large amounts of collagen, which provides structural integrity to the skin. The dermis contains a layer of small blood vessels and capillaries that provide oxygen and nutrients to the rest of the layers of skin.

As used herein, the term "tissue" means an aggregate of cells of a particular kind, together with their intercellular substance, that form a structural material of an animal or plant. At least one surface of the tissue must be accessible to electromagnetic radiation so that the invention can be carried out. The preferred tissue is the skin. Other tissues suitable for use with this invention include mucosal tissue and soft organs.

As used herein, "poration," "microporation," or any such similar term means the formation of a small hole or pore to a desired depth in or through the biological membrane, such as skin or mucous membrane, or the outer layer of an organism to lessen the barrier properties of this biological membrane to the passage of biological fluids, such as analytes from below the surface for analysis or the passage of permeants or drugs into the body for selected purposes, or for certain medical or surgical procedures. Preferably the hole or micropore will be no larger than about 1 mm (1000 μm) in diameter, and will extend to a selected depth, as described hereinafter.

As used herein, "biological membrane" or "membrane" means any tissue material present within a living organism forming a barrier between distinct tissues or areas of an organism, or between tissue of an organism and the external environment, and includes without limitation: the skin, mucosal membranes; buccal membranes; the outer layers of a plant; and the walls of a cell or a blood vessel.

"Electroporation" means a process by which electrical current is applied through tissue by electrodes spaced apart on or in the tissue to temporarily increase the permeability of the tissue membranes to collection of fluids therefrom, or delivery of permeants thereto. It involves the delivery of pulses of electrical energy of relative short duration to cause the voltage potential developed across the targeted tissue structure to be sufficiently greater than a threshold level to produce the desired electroporation. The parameters typical of electroporation and the thresholds for effective operation under many operating conditions are well known in the art, and are discussed in several articles, including "Electroporation Of Mammalian Skin: A Mechanism to Enhance Transdermal Drug Delivery," Proc. Nat'l Acad. Sci., 90:1054-1058 (1993) by Prausnitz et al., and "Methods For In Vivo Tissue Electroporation Using Surface Electrodes," Drug Delivery, 1:1265-131 (1993) by Prausnitz et al.

As used herein, "micropore" or "pore" means an opening formed by the microporation method.

As used herein, the term "bioactive agent," "permeant," "drug," or "pharmacologically active agent" or "deliverable substance" or any other similar term means any chemical biological material or compound suitable for delivery by the methods previously known in the art and/or by the methods taught in the present invention, that induces a desired effect, such as a biological or pharmacological effect, which may include but is not limited to (1) having a prophylactic effect on the organism and preventing an undesired biological effect such as preventing an infection, (2) alleviating a condition caused by a disease, for example, alleviating pain or inflammation caused as a result of disease, (3) either alleviating, reducing, or completely eliminating the disease from the organism, and/or (4) the placement within the viable tissue layers of the organism of a compound or formulation which can react, optionally in a reversible manner, to changes in the concentration of a particular analyte and in so doing cause a detectable shift in this compound or formulation's measurable response to the application of energy to this area which may be electromagnetic, mechanical or acoustic.

The term "heated probe" means a probe, preferably solid phase, which is capable of being heated in response to the application of electrical or electromagnetic (optical) energy thereto. For simplicity, the probe is referred to as a "heated probe" which includes a probe in a heated or unheated state, but which is heatable.

The present invention is directed to creating an electroporation effect to selectively enhance the permeability of selected structures within tissue, including but not limited to, cell membrane walls, the membranes separating different tissue types and the walls of the capillaries and blood vessels present in the dermis, to allow a greater out-flux of the aqueous fluid from within the blood volume into the interstitial spaces or to allow a greater influx of a compound introduced into these surrounding tissues and hence the blood stream. This method may be used in conjunction with additional permeation enhancement measures of the skin tissues to facilitate the external collection of a volume of interstitial fluid sufficient to allow an assay to be run on the interstitial fluid for the quantification of a selected analyte, such as glucose, or for the delivery of a permeant into the body.

It is known that the physical size of the capillary and vessel cross-section is several times larger than the dermal and epidermal cells also present in the current path, and the potential drop across all of these structures is known to occur almost exclusively at the outer membrane, or in the case of the capillaries or blood vessels, at the epithelial cell layer comprising the main barrier structure within the wall of the capillary or vessel. Consequently, a current density sufficient to produce a potential drop exceeding the nominal threshold (preferably greater than about 1 volt) to achieve electroporation across the epithelial cell layer is not sufficient to electroporate the membranes present in other tissue structures, such as the cell walls of the epidermal cells, through which the current is flowing, hence allowing a selective electroporation of only the targeted membranes.

FIG. 1 depicts the steps of the overall process 100 according to the present invention. Various devices and techniques for performing each of the steps in FIG. 1 are shown and described hereinafter. Briefly, the overall process involves forming at least one micropore to a predetermined depth range through a surface of the tissue; positioning at least a first electrode electrically coupled to the at least one micropore and a second electrode spaced apart from the first electrode; applying an electrical voltage between the first and second electrodes sufficient to produce a desired electroporation in the tissue present in the induced current path.

Step 110 involves forming micropores in the tissue to be treated. At least one micropore is formed, though as will become more apparent hereinafter, multiple micropores may be formed. The micropore is formed through a surface of the tissue, such as skin, to a predetermined depth range into the tissue. For example, at least one microporation in the outer layer of the epidermis is formed to allow the high impedance layer of the stratum corneum to be eliminated from the current path. The depth to which a micropore is created is described in co-pending U.S. Provisional Application Ser. No. 60,077,135, Attorney Docket No., filed on even date, and entitled "Integrated Poration, Harvesting and Analysis Device, and Method Therefor," the entirety of which is incorporated herein by reference. In addition, microporation depth control is also described in co-pending U.S. application Ser. No. 09,036,053 entitled "Method and Apparatus For Enhancing Flux Rates Of A Fluid In A Microporated Biological Tissue," Attorney Docket No., filed on even date, the entirety of which is incorporated herein by reference.

Preferably, at least two micropores are formed some distance apart in the locations where the electrodes are to be placed. These micropores are created by one of the several methods such as those disclosed in the aforementioned co-pending U.S. application Ser. No. 08/776,863, and described hereinafter. The micropores range in size from 1 to 1000 microns across and from 20 to 1000 microns deep, but preferably 80 to 500 microns across and 40 to 180 microns deep.

Next, in step 120, electrodes are applied or positioned (if not already in position) about the microporation(s) on the tissue. This step involves the mechanical positioning of at least first and second electrodes such that at least one of the electrodes is electrically coupled to the micropore. That is, at least one of the electrodes (i.e., the first electrode) is positioned proximate the micropore so that the dominant or preferred current path to that electrode, induced by the electrical voltage between it and the second electrode is through the micropore. This assists in ensuring that at least some, if not the preferred, current density paths through the tissue intersects at least some of the capillary loop structures and blood vessels present in these tissues. The second electrode can be coupled to any other tissue surface, acting to complete the current path through the tissue with respect to the first electrode.

On the other hand, each of the first and second electrodes may be electrically coupled to micropores formed in the tissue separated from each other. The electrodes may electrically penetrate into the micropore through a compliant electrolyte, e.g., a conductive hydrogel or a saline solution, placed on the contacting surface to facilitate electrical contact into the micropores. Additionally, according to a preferred embodiment, the same elements that are used to thermally microporate the tissue are used as electroporation electrodes after the thermal microporation process has been completed.

Step 130, an optional step, involves deforming the tissue surface so that it bows or bulges between the microporations. Depending on the depth of the micropores and the penetration of the electrode into them, a small deformation of the tissue surface into a bowed shape is created between the micropores such that a line drawn between the micropores would intersect the targeted tissue structures, such as capillaries and vessels in, for example, the dermis.

Next, in step 140, an electrical voltage pulse or series of voltage pulses is applied between the first and second electrodes of sufficient magnitude or amplitude such that the resulting current flow through the intervening tissue, including the targeted structures causes a potential drop across these targeted tissue structures, such as capillary walls, which exceeds the electroporation threshold for these tissue structures present in the current path. The pulsing scheme can include the modulation of pulse amplitude, pulse timing, pulse polarity and geometrical direction of the pulses to achieve desired electroporation effects. The duration of the pulse is relatively short, such as (1 μs to 10 ms) with an amplitude designed to ensure that the potential drop across the targeted membrane structures in the current path nominally exceeds a 1 volt potential, the value known in the art as being the nominal threshold level at which effective poration of a membrane begins to occur. The pulse duration and amplitude applied to the electrodes depends on the specific tissue to which the electrodes are applied, the spacing between the electrodes, and other parameters that affect the impedance of the current path and the coupling of the electrodes to the tissue.

In step 150, biological fluid exuded from the microporated and electroporated tissue is collected for analysis, or a substance, such as a drug or other bioactive agent is delivered into the permeability-enhanced tissue.

Turning to FIGS. 2A and 2B, an apparatus for electroporating and/or microporating and electroporating tissue is described. Briefly, the apparatus comprises a heated probe suitable for conducting heat to a surface of the tissue to form at least one micropore therein; at least first and second electrodes spaced apart from each other on the tissue, with the first electrode being electrically coupled to the micropore; and control means for supplying energy to the heated element so as to form the at least one micropore, and for applying electrical voltage between the first and second electrodes for electroporating the tissue.

Specifically, the apparatus, shown generally at reference numeral 200, comprises at least two electrodes 210 and 212. At least one of the electrodes is positioned in one of the micropores M1 and M2 formed through the tissue surface TS, such as skin, and the other electrode is spaced from it and placed on the tissue surface to complete the current path through the tissue. Preferably, the electrodes 210 and 212 are placed in micropores M1 and M2. The electrodes 210 and 212 may be supported by a tissue-contacting layer 214. Electrical voltage is applied between the electrodes 210 and 212 by energy supply means, included as part of a control system 220. The control system 220 includes the appropriate circuitry to supply electrical current and electrical voltage, and to control an optical energy source (if needed). Electrical contact of the electrodes 210 and 212 with the micropores can be achieved with a compliant electrolyte, such as a conductive hydrogel or a saline solution placed on the surface of the tissue in the micropores. Once again, each electrode is preferably positioned proximate a micropore so as to be electrically coupled thereto.

The micropores M1 and M2 are formed prior to energization of the electroporation electrodes 210 and 212. These micropores may be formed in several ways, including thermal ablation via a heated probe by electrical or optical energy. Optical or laser thermal ablation involves placing a photosensitizing assembly, including an optically absorbing compound such as a dye, in contact with the surface of the tissue, optical energy is focused on the photosensitizing assembly which heats it, and the heat is transferred to the surface of the tissue, forming a micropore. The details of this technique are well described in all of the co-pending applications, which are incorporated herein by reference. In this case, a source of optical energy (not shown), controlled by the control system 220, is optically coupled to the photosensitizing assembly placed on the surface of the tissue. Alternatively, the skin could be microporated using a laser which emits at a wavelength which is directly absorbed by the tissue to be removed such as an excimer, holmium, erbium, or CO2 laser or the like. The use of direct laser absorption to form micropores is well known in the art. The application of the electroporation methods to which this invention is directed are suitably compatible with those other methods for forming the micropores in the skin.

In accordance with a preferred embodiment of the present invention, the electrodes 210 and 212 also serve as electrically heated probes used for thermally ablating the tissue to form the micropores M1 and M2. Such electrically heated probes for microporating tissue are disclosed in the aforementioned co-pending U.S. application Ser. No. 08/776,863. Specifically, each electrode 210 and 212 comprises an electrically heated probe consisting of an electrically heated wire which is responsive to electrical current supplied therethrough. As shown in FIG. 2B, during the microporation stage or cycle, electrical current is coupled via conductor leads 222 and 224 to electrode 210 to supply an electrical current therethrough, and electrical current is also coupled via conductor lead lines 226 and 228 to electrode 212. On the other hand, during the electroporation stage or cycle, a voltage is applied to the conductors 222 and 224, relative to a voltage potential applied to conductors 226 and 228, causing electrode 210 to be at a positive potential with respect to electrode 212, or alternatively at a negative potential with respect to electrode 212 (depending on the polarity desired). Thus, the electrically heated probes described above are dual purpose in that they can perform the functions of microporation and of electroporation.

FIGS. 3 and 4 illustrate the incorporation of dual purpose electrically heated probes as part of an integrated fluid harvesting, collection and analysis device, shown generally at reference numeral 300. The device 300 includes a tissue-contacting layer 310 having an electrically heated probe surface 320. The device 300 further comprises a detecting layer 340 such as a photometric sensor or an electrochemical biosensor, both of which are capable of providing an indication of a characteristic of a collected biological fluid, such as the level of an analyte in interstitial fluid. A meter (not shown) is coupled by a meter-interface layer 330, to the detecting layer 340 either electrically or optically, depending on the type of detecting layer used. The integrated device 300 is more fully disclosed in U.S. application Ser. No. 60,077,135, entitled "Integrated Poration, Harvesting And Analysis Device, And Method Therefor."

As shown in more detail in FIG. 4, the electrically heated probe surface 320 comprises several electrically heated probes 322 provided on the bottom surface of the tissue-contacting layer 310. Three electrical heated probes 322 are shown, but any number of them may be provided. Each of the three heated probes 322 are connected to a pair of the electrical conductors 324, 325, 326, 327, 328 and 329 as shown. The electrical conductors extend the length of the tissue-contacting layer 310 and terminate at a plurality of points near the lower end of the integrated device 300. Each electrically heated probe 322 is connected to a control system by the respective pairs of conductors {324, 325}, {326, 327} and {328, 329} as shown in FIG. 4.

Each electrically heated probe 322 can be activated individually through the appropriate selection and energization of the conductors 324, 325, 326, 327, 328 and 329. It may be advantageous to excite all electrically heated probes 322 simultaneously, thereby enabling either a series or parallel wiring design, reducing the number of interconnections to the device and facilitating a more rapid poration process. If only one electrically heated probe 322 is provided, then at least two conductors are provided for supplying electric current to it.

The electrically heated probes 322 function as solid thermal probes and are electrically heated so that a temperature of the tissue, if skin, is raised to greater than 123 C. The electrically heated probes 322 comprise, for example a 100 to 500 micron long, 50 micron diameter, tungsten wire element. A number of human clinical studies have been performed wherein the surface microporation was achieved by using these types of wires as the electrically heated probe. These tungsten elements are typically laid flat against some form of a backing which naturally limits the depth of penetration of the wire element into the tissue as it is being microporated (by virtue of the size of the element). The temperature of the heated element is modulated as needed to effect the microporation process. Such pulse duty cycle and modulation techniques are disclosed in co-pending U.S. application Ser. No. 08/776,863.

The graph of FIG. 5 shows impedance data between two electrically heated probes (tungsten elements) spaced apart by 2.5 mm on human skin. The graph shows that immediately after even a first pulse is applied, the electrical impedance between them through the body's core drops by several orders of magnitude and then continues to drop with each subsequent pulse as the probe enters deeper into the viable skin tissues, making this an ideal electrode for delivering the desired electroporation pulse. The thermal pulses each reached a maximum of 700°C and had a duration of 3 ms. The inherent and perfect alignment between the electrically heated probe and the micropore it has created also simplifies the process, requiring no additional steps or hardware to position the electrode.

Moreover, that the electrically heated probes 322 also function as electroporation electrodes is particularly advantageous because they are already contacting the moist viable epidermis after the microporation process has been performed. With these electrodes in place, a mild current, either DC or AC can be established from one or more electrodes to another one or more electrodes, or from one (or more) electrodes to a separate electrode by the application of a suitable voltage between the electrodes, to induce an electromagnetic force field in the ISF-laden tissues beneath the stratum corneum to enhance the outflow of the ISF sample.

A similar technique can be applied with the use of an optically heated probe in an integrated device, such as that disclosed in the co-pending application filed on even date. However, additional electrodes, such as those shown in the device of FIGS. 3 and 4, are additionally required in order to deliver the electroporation energy to the microporated tissue. These additional electrodes can be conveniently formed on the lower surface of the photosensitizing assembly or layer using a lithographic process to create a printed circuit type pattern of conductive traces, portions of which serve as the electrodes on the tissue-contacting side of this layer. This pattern of conductors registers the electrodes to the micropores to be formed, so that at least one electrode in the conductive trace is electrically coupled to a micropore.

Referring back to FIG. 2A, when a voltage is applied between the electrodes, so as to drive a current between them through the tissue, current flux lines EF are created, such that at least one or more of them pass through the intervening targeted tissue structures, such as the capillaries, CP in the tissue. These flux lines (current paths) preferably go as deep as the papillary dermis so as to affect the capillaries therein. The voltage pulsing scheme may consist of a first voltage pulse of a polarity followed by a second voltage pulse of an opposite polarity. This causes current to flow in both directions between the electrodes. An advantage of redirecting the current flow in both directions at a given set of micropores is that by presenting the body with a balanced AC signal, no cumulative electrical polarization is established. This balanced signal has been shown to minimize the sensation to an individual.

Depending on the depth of the micropores and the penetration of the electrodes into them, the tissue may be deformed by a predetermined amount D so as to further increase the number of electric flux lines that pass through specific targeted tissue structures, such as capillaries in the tissue. For example, the tissue may be deformed by as much as 0.5 mm. This deformation could be achieved by several means. For example, the tissue could be simply squeezed together between the microporations.

FIG. 6 illustrates a mechanical element that can be used to impart a bow in the tissue. The mechanical element 400 has a small opening 410 therein (2 mm to 4 mm). Applying force to the mechanical element 400 presses the device onto the skin at the poration site and thus causes the surface of the tissue, i.e., the skin, to bow or bulge into the opening 410 and between the electrodes supported on the device 300. This bulge of the tissue enhances the effect that the current paths created during electroporation can have in the tissue, as shown in FIG. 2. Furthermore, this induces a positive pressure gradient in the ISF, forcing the fluid towards the micropore(s) where it can exit the tissue and enter a fluid management chamber of the device.

FIG. 7 illustrates another means of creating a bulge in the tissue. A vacuum chamber 500 can be created above the surface of the tissue which is to be electroporated, contained by a sealed container. A source or means of negative pressure, such as a pump 510 is coupled to an enclosed chamber which is sealed over the area of the tissue to be treated. The tissue is sucked into the chamber 500 using a mild suction, wherein the dimensions and shape of the opening to the chamber 500 and the amount of suction applied produce the desired amount of deformation of the tissue surface. Other suction means, such as a syringe or diaphragm are also suitable.

The use of electroporation coupled with microporation achieves significant advantages. Specifically, in the case of conventional electroporation, where pulses exceeding 50 to 150 volts are routinely used to electroporate the stratum comeum or mucosal layer, in the microporated tissue environment of the present invention, pulses of only a few volts can be sufficient to electroporate the cell, capillary or other membranes within the targeted tissue. This is principally due to the dramatic reduction in the number of insulating layers present between the electrodes once the outer surface of the tissue has been opened, as reflected by the graph of FIG. 5.

The manner in which the electroporation pulses are applied may vary. For example, a plurality of micropores spaced apart from each other in the tissue may be formed, and the electrical pulses are then applied in multiple directions between different sets (pairs or more) of electrodes to facilitate the electroporation of a larger percentage of the area of the targeted structures in the intervening tissue such as capillary walls. This multi-directional cross firing can be achieved with a plurality of electrically heated probes, similar to those shown in FIGS. 3 and 4. FIG. 8 illustrates such an embodiment, in which an 3×3 array 600 of electrically heated probes 610 is applied to the surface of the tissue. The electrically heated probes 610 also serve as the electroporation electrodes. The array can be formed using well known circuit printing technologies, such as etching, lithographic film deposition, etc. A suitable electrically heated poration element is then placed onto the appropriate conductors etched onto a circuit board/substrate. In this embodiment, all or selected ones of the heated probes 610 are energized to form micropores in the tissue. Then, sets of the heated probes 610, which are already suitably electrically coupled to their respective micropores, are connected to a source of AC or DC voltage to create a current distribution between them. Voltage is applied between different sets of poration elements, now acting as electroporation electrodes, at the different micropores so as to change the direction of the electroporation through the tissue. Successive pulses are preferably either in an opposite polarity with respect to the same set of electrodes and/or are between different sets of electrodes. Each possible path can be energized in either polarity, or toggled back and forth between polarities. The advantages of redirecting the current flow in both directions at a given set of micropores is that by presenting the body with a balanced AC signal, no cumulative electrical polarization is established. Furthermore, this multi-directional current control has been shown to dramatically reduce the sensation of the subject during the electroporation process as has the setting of the pulse parameters below certain peak voltage levels and with a duration of each pulse kept to a minimum, preferably under a few milliseconds.

It is well known in the art that electroporation can cause openings to form, temporarily, in the cell membranes and other internal tissue membranes. By having breached the surface of the tissue, such as the stratum corneum, mucosal layer or outer layer of a plant, and if desired the epidermis and dermis, or deeper into a plant, electroporation can be used with parameters tailored to act selectively on these underlying tissue barriers. For any electromagnetic energy enhancement means, the specific action of the enhancement can be designed to focus on any part of the micropore, e.g., on the bottom of the micropore by focusing the discharge of the electrodes, phasing of multiple electrodes or other field forming methods and devices and the like. Alternatively, the enhancement can be focused more generally on the entire micropore or the area surrounding the pore.

The mode of operation of electroporation when applied after the microporation of the tissue, has the advantage of being able to use operational parameters which would be useless for un-microporated, intact tissue surface conditions. In particular, the operational settings useable when applied after the microporation of the skin or mucosal layer or the outer layer of a plant are generally close to those typically used in in vitro applications where single cell membranes are opened up for the delivery of a substance. Examples of these parameters are well known in the literature. For example, Sambvrook et al., Molecular Cloning: A Laboratory Manual, 2d Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1989.

Still another enhancement which may be used in conjunction with the electroporation techniques described herein is the application of sonic energy. Suitable sonic energy techniques are described in the aforementioned co-pending applications.

Various modifications and alterations of this invention will become apparent to those skilled in the art without departing from the scope and spirit of this invention, and it should be understood that this invention is not to be unduly limited to the illustrative embodiments set forth herein.

Eppstein, Jonathan A., Hatch, Michael R.

Patent Priority Assignee Title
10149970, Jun 18 2012 Method and system for delivering solution into the pores of recipient human skin
10245107, Mar 15 2013 Cynosure, LLC Picosecond optical radiation systems and methods of use
10285757, Mar 15 2013 Cynosure, LLC Picosecond optical radiation systems and methods of use
10305244, Apr 18 2012 Cynosure, LLC Picosecond laser apparatus and methods for treating target tissues with same
10369360, Dec 03 2009 Northwestern University Devices for material delivery, electroporation, sonoporation, and/or monitoring electrophysiological activity
10434324, Apr 22 2005 Cynosure, LLC Methods and systems for laser treatment using non-uniform output beam
10493199, Mar 30 2006 MannKind Corporation Multi-cartridge fluid delivery device
10500413, Jun 19 2002 PALOMAR MEDICAL TECHNOLOGIES, LLC Method and apparatus for treatment of cutaneous and subcutaneous conditions
10525194, Apr 23 2003 MannKind Corporation Hydraulically actuated pump for fluid administration
10556123, Jun 19 2002 PALOMAR MEDICAL TECHNOLOGIES, LLC Method and apparatus for treatment of cutaneous and subcutaneous conditions
10575897, Apr 01 2004 The General Hospital Corporation Method and apparatus for dermatological treatment and tissue reshaping
10581217, Apr 18 2012 Cynosure, LLC Picosecond laser apparatus and methods for treating target tissues with same
10765478, Mar 15 2013 CYNOSURCE, LLC Picosecond optical radiation systems and methods of use
10849687, Aug 02 2006 Cynosure, LLC Picosecond laser apparatus and methods for its operation and use
10898116, Mar 15 2013 Cambridge Medical Technologies LLC Methods of manufacture to optimize performance of transdermal sampling and analysis device
10966785, Aug 02 2006 Cynosure, LLC Picosecond laser apparatus and methods for its operation and use
11095087, Apr 18 2012 Cynosure, LLC Picosecond laser apparatus and methods for treating target tissues with same
11375931, Aug 08 2019 Cambridge Medical Technologies LLC Non-invasive transdermal sampling and analysis device incorporating an electrochemical bioassay
11418000, Feb 26 2018 Cynosure, Inc; Cynosure, LLC Q-switched cavity dumped sub-nanosecond laser
11446086, Mar 15 2013 Cynosure, LLC Picosecond optical radiation systems and methods of use
11607156, Apr 05 2019 Cambridge Medical Technologies LLC Non-invasive transdermal sampling and analysis device incorporating redox cofactors
11633129, Apr 05 2019 Cambridge Medical Technologies LLC Non-invasive transdermal sampling and analysis device incorporating redox cofactors
11642456, Apr 23 2003 MannKind Corporation Hydraulically actuated pump for fluid administration
11664637, Apr 18 2012 Cynosure, LLC Picosecond laser apparatus and methods for treating target tissues with same
11712299, Aug 02 2006 Cynosure, LLC. Picosecond laser apparatus and methods for its operation and use
11791603, Feb 26 2018 Cynosure, LLC. Q-switched cavity dumped sub-nanosecond laser
6183434, Jul 03 1996 Nitto Denko Corporation Multiple mechanical microporation of skin or mucosa
6352506, Jul 14 1998 PASSPORT TECHNOLOGIES, INC Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport
6451040, Sep 01 2000 Ascensia Diabetes Care Holdings AG Adjustable endcap for lancing device
6482604, Sep 04 1998 Powderject Research Limited Non-or minimally invasive monitoring methods using particle delivery methods
6508785, Mar 06 1998 Nitto Denko Corporation Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
6527716, Dec 30 1997 Nitto Denko Corporation Microporation of tissue for delivery of bioactive agents
6537264, Jun 18 1996 ALZA Corporation Device and method for enhancing transdermal flux of agents being sampled
6597946, Nov 09 1998 Syneron Medical Ltd Electronic card for transdermal drug delivery and analyte extraction
6602678, Sep 04 1998 Powderject Research Limited Non- or minimally invasive monitoring methods
6611706, Nov 09 1998 Syneron Medical Ltd Monopolar and bipolar current application for transdermal drug delivery and analyte extraction
6615079, Nov 09 1998 Syneron Medical Ltd Transdermal drug delivery and analyte extraction
6629949, May 08 2000 TecPharma Licensing AG Micro infusion drug delivery device
6659982, May 08 2000 TecPharma Licensing AG Micro infusion drug delivery device
6692456, Jun 08 1999 PASSPORT TECHNOLOGIES, INC Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor
6706032, Jun 08 2000 Massachusetts Institute of Technology; General Hospital Corporation, The Localized molecular and ionic transport to and from tissues
6708060, Nov 09 1998 Syneron Medical Ltd Handheld apparatus and method for transdermal drug delivery and analyte extraction
6711435, Nov 09 1998 Syneron Medical Ltd Transdermal drug delivery and analyte extraction
6730028, Jul 14 1998 PASSPORT TECHNOLOGIES, INC Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport
6733485, May 25 2001 Boston Scientific Neuromodulation Corporation Microstimulator-based electrochemotherapy methods and systems
6790179, Aug 01 2001 JOHNSON & JOHNSON CONSUMER INC ; JOHNSON & JOHNSON CONSUMER COMPANIES, LLC Method of examining and diagnosing skin health
6797276, Nov 14 1996 GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
6840910, Aug 01 2001 JOHNSON & JOHNSON CONSUMER INC ; JOHNSON & JOHNSON CONSUMER COMPANIES, LLC Method of distributing skin care products
6855117, Aug 01 2001 JOHNSON & JOHNSON CONSUMER INC ; JOHNSON & JOHNSON CONSUMER COMPANIES, LLC Method of treating the skin of a subject
6951411, Jun 18 1999 PASSPORT TECHNOLOGIES, INC Light beam generation, and focusing and redirecting device
6952604, Dec 21 2001 Becton, Dickinson and Company Minimally-invasive system and method for monitoring analyte levels
6974451, May 15 1997 PALOMAR MEDICAL TECHNOLOGIES, LLC Light energy delivery head
7037499, Nov 14 1996 The United States of America as represented by the Secretary of the Army Adjuvant for transcutaneous immunization
7077840, May 15 1997 PALOMAR MEDICAL TECHNOLOGIES, LLC Heads for dermatology treatment
7123957, Nov 09 1998 Syneron Medical Ltd Transdermal drug delivery and analyte extraction
7135033, May 23 2002 PALOMAR MEDICAL TECHNOLOGIES, LLC Phototreatment device for use with coolants and topical substances
7141034, Jun 08 2000 PASSPORT TECHNOLOGIES, INC Transdermal drug delivery device, method of making same and method of using same
7162297, Sep 22 2000 Apparatus and applicator patch for transdermal substance delivery
7164942, Nov 09 1998 TRANSPHARMA MEDICAL LTD Handheld apparatus and method for transdermal drug delivery and analyte extraction
7204832, Dec 02 1996 PALOMAR MEDICAL TECHNOLOGIES, LLC Cooling system for a photo cosmetic device
7220254, Dec 31 2003 PALOMAR MEDICAL TECHNOLOGIES, LLC Dermatological treatment with visualization
7258673, Jun 06 2003 Cilag GmbH International; Lifescan IP Holdings, LLC Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein
7276058, Jun 19 2002 PALOMAR MEDICAL TECHNOLOGIES, LLC Method and apparatus for treatment of cutaneous and subcutaneous conditions
7309335, Dec 31 2003 PALOMAR MEDICAL TECHNOLOGIES, LLC Dermatological treatment with visualization
7335377, Oct 31 2002 Syneron Medical Ltd Transdermal delivery system for dried particulate or lyophilized medications
7351252, Jun 19 2002 PALOMAR MEDICAL TECHNOLOGIES, LLC Method and apparatus for photothermal treatment of tissue at depth
7363075, Oct 31 2002 Syneron Medical Ltd Transdermal delivery system for dried particulate or lyophilized medications
7378097, Nov 14 1996 The United States of America as represented by the Secretary of the Army Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant
7383084, Oct 31 2002 Syneron Medical Ltd Transdermal delivery system for dried particulate or lyophilized medications
7392080, Mar 11 2002 PASSPORT TECHNOLOGIES, INC Transdermal drug delivery patch system, method of making same and method of using same
7395111, Oct 31 2002 Syneron Medical Ltd Transdermal delivery system for water insoluble drugs
7415306, Oct 31 2002 Syneron Medical Ltd Transdermal delivery system for anti-emetic medication
7431719, Dec 02 1996 PALOMAR MEDICAL TECHNOLOGIES, LLC System for electromagnetic radiation dermatology and head for use therewith
7438926, Sep 08 2000 ALZA Corporation Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
7527802, Feb 13 2001 GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY, THE; GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SCRETARY OF THE ARMY, THE Vaccine for transcutaneous immunization
7530968, Apr 23 2003 MannKind Corporation Hydraulically actuated pump for long duration medicament administration
7531967, Mar 01 2001 PALOMAR MEDICAL TECHNOLOGIES, LLC Flashlamp drive circuit
7540869, Dec 27 2001 PALOMAR MEDICAL TECHNOLOGIES, LLC Method and apparatus for improved vascular related treatment
7597692, Jun 08 2000 General Hospital Corporation, The Microscission processes and procedures
7611723, Mar 26 2002 NANOCYTE INC Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
7632522, Sep 28 2000 NANOCYTE INC Use of stinging cells/capsules for the delivery of active agents to keratinous substances
7662404, Oct 31 2002 Syneron Medical Ltd Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
7695469, Jan 25 2007 BIOLASE, INC Electromagnetic energy output system
7731867, Aug 15 2003 Lifescan IP Holdings, LLC Electrochemical sensor ink compositions, electrodes, and uses thereof
7751895, Jun 03 2005 BIOLASE, INC Tissue treatment device and method
7758561, Dec 30 1997 PASSPORT TECHNOLOGIES, INC Microporation of tissue for delivery of bioactive agents
7758621, May 15 1997 PALOMAR MEDICAL TECHNOLOGIES, LLC Method and apparatus for therapeutic EMR treatment on the skin
7763016, May 15 1997 PALOMAR MEDICAL TECHNOLOGIES, LLC Light energy delivery head
7776373, Nov 19 2004 Eteka LLC Apparatus and method for the enhancement of food properties and food prepared therefrom
7815630, Jan 25 2007 BIOLASE, INC Target-close electromagnetic energy emitting device
7850676, Apr 19 2004 GEARBOX, LLC System with a reservoir for perfusion management
7857767, Apr 19 2004 GEARBOX, LLC Lumen-traveling device
7867217, Aug 09 2007 GEARBOX, LLC System with a reservoir for perfusion management
7871402, Apr 19 2004 GEARBOX, LLC System with a reservoir for perfusion management
7879023, Aug 09 2007 GEARBOX, LLC System for perfusion management
7896819, Oct 21 2004 Ascensia Diabetes Care Holdings AG Method of determining the concentration of an analyte in a body fluid and system in therefor
7914499, Mar 30 2006 MannKind Corporation Multi-cartridge fluid delivery device
7935107, May 15 1997 PALOMAR MEDICAL TECHNOLOGIES, LLC Heads for dermatology treatment
7942915, May 23 2002 PALOMAR MEDICAL TECHNOLOGIES, LLC Phototreatment device for use with coolants
7942916, May 23 2002 PALOMAR MEDICAL TECHNOLOGIES, LLC Phototreatment device for use with coolants and topical substances
7998060, Apr 19 2004 GEARBOX, LLC Lumen-traveling delivery device
7998509, Sep 28 2000 NanoCyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
8000784, Apr 19 2004 GEARBOX, LLC Lumen-traveling device
8002768, May 15 1997 PALOMAR MEDICAL TECHNOLOGIES, LLC Light energy delivery head
8016810, Jun 23 2003 Syneron Medical Ltd Transdermal delivery system for cosmetic agents
8016811, Oct 24 2003 PASSPORT TECHNOLOGIES, INC Method for transdermal delivery of permeant substances
8019413, Mar 19 2007 GEARBOX, LLC Lumen-traveling biological interface device and method of use
8024036, Mar 19 2007 GEARBOX, LLC Lumen-traveling biological interface device and method of use
8033825, Aug 31 1995 BIOLASE, INC Fluid and pulsed energy output system
8062660, Sep 28 2000 NanoCyte Inc. Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
8070726, Apr 23 2003 MannKind Corporation Hydraulically actuated pump for long duration medicament administration
8092549, Sep 24 2004 GEARBOX, LLC Ciliated stent-like-system
8109924, May 15 1997 PALOMAR MEDICAL TECHNOLOGIES, LLC Heads for dermatology treatment
8116860, Mar 11 2002 PASSPORT TECHNOLOGIES, INC Transdermal porator and patch system and method for using same
8133505, Oct 31 2002 Syneron Medical Ltd Transdermal delivery system for dried particulate or lyophilized medications
8145295, Apr 12 2006 GEARBOX, LLC Methods and systems for untethered autofluorescent imaging, target ablation, and movement of untethered device in a lumen
8152797, Jan 25 2007 BIOLASE, INC Electromagnetic energy output system
8160680, Apr 12 2006 GEARBOX, LLC Autofluorescent imaging and target ablation
8180436, Apr 12 2006 GEARBOX, LLC Systems for autofluorescent imaging and target ablation
8182473, Dec 02 1996 PALOMAR MEDICAL TECHNOLOGIES, LLC Cooling system for a photocosmetic device
8268332, Apr 01 2004 The General Hospital Corporation Method for dermatological treatment using chromophores
8281675, Oct 17 2007 Syneron Medical Ltd Dissolution rate verification
8287912, Sep 28 2000 NanoCyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
8291913, Jun 14 2004 SOLTA MEDICAL, INC Adaptive control of optical pulses for laser medicine
8323263, Apr 19 2004 GEARBOX, LLC System with a reservoir for perfusion management
8328794, Dec 02 1996 PALOMAR MEDICAL TECHNOLOGIES, LLC System for electromagnetic radiation dermatology and head for use therewith
8328796, May 15 1997 PALOMAR MEDICAL TECHNOLOGIES, LLC Light energy delivery head
8333874, Dec 09 2005 Cambridge Medical Technologies LLC Flexible apparatus and method for monitoring and delivery
8337482, Apr 19 2004 GEARBOX, LLC System for perfusion management
8337493, Apr 19 2002 Syneron Medical Ltd Handheld transdermal drug delivery and analyte extraction
8337868, Mar 26 2002 NanoCyte Inc. Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
8346347, Sep 15 2005 PALOMAR MEDICAL TECHNOLOGIES, LLC Skin optical characterization device
8353896, Apr 19 2004 GEARBOX, LLC Controllable release nasal system
8361013, Apr 19 2004 GEARBOX, LLC Telescoping perfusion management system
8361014, Apr 19 2004 GEARBOX, LLC Telescoping perfusion management system
8361053, Mar 30 2006 MannKind Corporation Multi-cartridge fluid delivery device
8361056, Apr 19 2004 GEARBOX, LLC System with a reservoir for perfusion management
8364228, Dec 09 2005 Cambridge Medical Technologies LLC Appartus and method for continuous real-time trace biomolecular sampling, analysis, and delivery
8372032, Aug 09 2007 GEARBOX, LLC Telescoping perfusion management system
8419719, Jan 25 2007 BIOLASE, INC Target-close electromagnetic energy emitting device
8485818, Dec 04 2009 BIOLASE, INC Fluid controller
8486441, Sep 28 2000 NanoCyte Inc. Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
8512219, Apr 19 2004 GEARBOX, LLC Bioelectromagnetic interface system
8517958, Jun 08 2000 PASSPORT TECHNOLOGIES, INC Transdermal integrated actuator device, methods of making and using same
8545497, Mar 24 2004 University College Cork - National University of Ireland, Cork Apparatus for use in the prophylaxis or treatment of tissue
8641689, Mar 11 2002 PASSPORT TECHNOLOGIES, INC Transdermal porator and patch system and method for using same
8660642, Apr 12 2006 GEARBOX, LLC Lumen-traveling biological interface device and method of use
8694092, Apr 12 2006 GEARBOX, LLC Lumen-traveling biological interface device and method of use
8706210, Mar 11 2002 PASSPORT TECHNOLOGIES, INC Transdermal integrated actuator device, methods of making and using same
8712515, Aug 22 2008 Method and apparatus for disease diagnosis and screening using extremely low frequency electromagnetic fields
8821443, Mar 30 2006 MannKind Corporation Multi-cartridge fluid delivery device
8834862, Apr 19 2005 NANOCYTE ISRAEL LTD Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
8911742, Jun 22 1998 The United States of America as represented by the Secretary of the Army Transcutaneous immunization without heterologous adjuvant
8915948, Jun 19 2002 PALOMAR MEDICAL TECHNOLOGIES, LLC Method and apparatus for photothermal treatment of tissue at depth
8936629, Apr 12 2006 GEARBOX, LLC Autofluorescent imaging and target ablation
9011329, Apr 19 2004 GEARBOX, LLC Lumenally-active device
9011419, Dec 05 2007 Syneron Medical Ltd Disposable electromagnetic energy applicator
9028536, Aug 02 2006 Cynosure, LLC Picosecond laser apparatus and methods for its operation and use
9033950, Oct 24 2003 PASSPORT TECHNOLOGIES, INC Method for transdermal delivery of permeant substances
9037229, Oct 09 2007 Syneron Medical Ltd Magnetic patch coupling
9072828, Apr 23 2003 MannKind Corporation Hydraulically actuated pump for long duration medicament administration
9089636, Jul 02 2004 MannKind Corporation Methods and devices for delivering GLP-1 and uses thereof
9101377, Jan 25 2007 BIOLASE, INC Electromagnetic energy output system
9125983, Apr 23 2003 MannKind Corporation Hydraulically actuated pump for fluid administration
9173837, Apr 19 2004 GEARBOX, LLC Controllable release nasal system
9198563, Apr 12 2006 GEARBOX, LLC Temporal control of a lumen traveling device in a body tube tree
9220917, Apr 12 2006 GEARBOX, LLC Systems for autofluorescent imaging and target ablation
9295858, Jul 16 2008 Syneron Medical, Ltd; Syneron Medical Ltd Applicator for skin treatment with automatic regulation of skin protrusion magnitude
9351792, Mar 27 2003 The General Hospital Corporation Method and apparatus for dermatological treatment and fractional skin resurfacing
9408530, Apr 12 2006 GEARBOX, LLC Parameter-based navigation by a lumen traveling device
9451913, Dec 10 2010 Cambridge Medical Technologies LLC Transdermal sampling and analysis device
9452013, Apr 01 2004 The General Hospital Corporation Apparatus for dermatological treatment using chromophores
9486616, Mar 11 2002 PASSPORT TECHNOLOGIES, INC Transdermal integrated actuator device, methods of making and using same
9504826, Feb 18 2009 Syneron Medical Ltd Skin treatment apparatus for personal use and method for using same
9511187, Apr 23 2003 MannKind Corporation Hydraulically actuated pump for fluid administration
9579380, Dec 31 1996 PASSPORT TECHNOLOGIES, INC Microporation of tissue for delivery of bioactive agents
9687599, Mar 30 2006 MannKind Corporation Multi-cartridge fluid delivery device
9780518, Apr 18 2012 Cynosure, LLC Picosecond laser apparatus and methods for treating target tissues with same
9801527, Apr 19 2004 GEARBOX, LLC Lumen-traveling biological interface device
9877673, Dec 10 2010 Cambridge Medical Technologies LLC Transdermal sampling and analysis device
9918665, Jan 03 2014 PASSPORT TECHNOLOGIES, INC Transdermal porator and patch system and method for using same
9919168, Jul 23 2009 PALOMAR MEDICAL TECHNOLOGIES, LLC Method for improvement of cellulite appearance
9968284, Dec 02 2011 Cambridge Medical Technologies LLC Anti-interferent barrier layers for non-invasive transdermal sampling and analysis device
RE42594, Oct 16 1998 Reliant Technologies, Inc. Tissue cooling rod for laser surgery
RE43881, Oct 16 1998 Reliant Technologies, Inc. Tissue cooling rod for laser surgery
RE46208, Oct 16 1998 Reliant Technologies, LLC Method for cryogenically treating tissue below the skin surface
Patent Priority Assignee Title
5137817, Oct 05 1990 AMOCO CORPORATION, A CORP OF INDIANA Apparatus and method for electroporation
5215520, Sep 17 1991 Centre Internationale de Recherches Dermatologiques Galderma (C.I.R.D. Method for delivering an active substance topically or percutaneously
5273525, Aug 13 1992 GENETRONICS, INC Injection and electroporation apparatus for drug and gene delivery
5318514, Aug 17 1992 GENETRONICS, INC Applicator for the electroporation of drugs and genes into surface cells
5445611, Dec 08 1993 Nitto Denko Corporation Enhancement of transdermal delivery with ultrasound and chemical enhancers
5458140, Nov 15 1993 Nitto Denko Corporation Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
5462520, Aug 17 1992 Genetronics, Inc. Transsurface drug delivery by electrofusion of microbubbles to the tissue surface
5547467, Jan 21 1988 Massachusetts Institute of Technology Method for rapid temporal control of molecular transport across tissue
5749847, Jan 21 1988 Massachusetts Institute of Technology Delivery of nucleotides into organisms by electroporation
APB15019034,
//////////////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Mar 06 1998SpectRx, Inc.(assignment on the face of the patent)
Mar 06 1998Altea Technologies, Inc.(assignment on the face of the patent)
Jul 09 1998HATCH, MICHAEL R ALTEA TECHNOLOGIES, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0093680229 pdf
Jul 09 1998EPPSTEIN, JONATHAN A ALTEA TECHNOLOGIES, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0093680229 pdf
Jul 09 1998HATCH, MICHAEL R SpectRx, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0093680229 pdf
Jul 09 1998EPPSTEIN, JONATHAN A SpectRx, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0093680229 pdf
Nov 07 2002ALTEA TECHNOLOGIES, INC ALTEA DEVELOPMENT CORP ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0136990145 pdf
Nov 08 2002ALTEA DEVELOPMENT CORP Altea Therapeutics CorporationCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0136990641 pdf
Nov 20 2002ALTEA DEVELOPMENT CORP Altea Therapeutics CorporationCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0132950519 pdf
Jan 08 2003ALTEA TECHNOLOGIES, INC ALTEA DEVELOPMENT CORP CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0137460511 pdf
Jun 28 2006SpectRx, IncEASTON HUNT CAPITAL PARTNERS, L P SECURITY AGREEMENT0180990750 pdf
Feb 22 2008SpectRx, IncGUIDED THERAPEUTICS, INC CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0328150426 pdf
Aug 27 2009Altea Therapeutics CorporationGE BUSINESS FINANCIAL SERVICES INC SECURITY AGREEMENT0233190608 pdf
Dec 03 2009GUIDED THEREAPEUTICS, INC Altea Therapeutics CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0328090154 pdf
Dec 03 2009GUIDED THERAPEUTICS, INC Altea Therapeutics CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0350040444 pdf
Apr 29 2010Altea Therapeutics CorporationMIDCAP FINANCIAL, LLC, AS AGENT AND AS A LENDERSECURITY AGREEMENT0244450142 pdf
Mar 30 2011MIDCAP FINANCIAL, LLC, AS AGENT AND AS A LENDERMIDCAP FUNDING III, LLC, AS AGENTASSIGNMENT OF SECURITY AGREEMENT0260650314 pdf
Apr 12 2011GE BUSINESS FINANCIAL SERVICES INC Altea Therapeutics CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0270210405 pdf
Nov 14 2011MIDCAP FUNDING III, LLC , AS ADMINISTRATIVE AGENT FOR THE LENDERSNitto Denko CorporationTRANSFER STATEMENT0340290552 pdf
Nov 14 2011MIDCAP FUNDING III, LLCNitto Denko CorporationASSET PURCHASE AGREEMENT0340170661 pdf
Nov 14 2011MIDCAP FUNDING III, LLCNitto Denko CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0296390866 pdf
Nov 14 2011Altea Therapeutics CorporationMIDCAP FUNDING III, LLC, AS SUCCESSOR IN INTEREST TO MIDCAP FINANCIAL, LLCFORECLOSURE NOTICE0272480676 pdf
Date Maintenance Fee Events
Jun 27 2003M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Jun 21 2007M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Jul 21 2011M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Feb 08 20034 years fee payment window open
Aug 08 20036 months grace period start (w surcharge)
Feb 08 2004patent expiry (for year 4)
Feb 08 20062 years to revive unintentionally abandoned end. (for year 4)
Feb 08 20078 years fee payment window open
Aug 08 20076 months grace period start (w surcharge)
Feb 08 2008patent expiry (for year 8)
Feb 08 20102 years to revive unintentionally abandoned end. (for year 8)
Feb 08 201112 years fee payment window open
Aug 08 20116 months grace period start (w surcharge)
Feb 08 2012patent expiry (for year 12)
Feb 08 20142 years to revive unintentionally abandoned end. (for year 12)